FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

896757004: Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4029093012 Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4029094018 Trastuzumab emtansine 160 mg powder for solution for infusion vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role Antineoplastic therapeutic role false Inferred relationship Some
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Is a Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) false Inferred relationship Some
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has unit of presentation Vial (unit of presentation) true Inferred relationship Some
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has manufactured dose form Powder for conventional release solution for infusion (dose form) true Inferred relationship Some
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Count of base of active ingredient un false Inferred relationship Some
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength numerator value 160 false Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has presentation strength denominator value un false Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Trastuzumab emtansine true Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Vial (unit of presentation) true Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Trastuzumab emtansine true Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Is a Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start